PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 88 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,436,245 | -35.2% | 138,500 | -10.5% | 0.00% | – |
| Q2 2023 | $2,214,846 | +537.2% | 154,668 | +217.7% | 0.00% | – |
| Q1 2023 | $347,583 | -58.1% | 48,681 | -34.2% | 0.00% | – |
| Q4 2022 | $830,414 | +30.8% | 74,012 | +29.1% | 0.00% | – |
| Q3 2022 | $635,000 | +43.7% | 57,342 | +9.5% | 0.00% | – |
| Q2 2022 | $442,000 | +14.5% | 52,372 | +84.8% | 0.00% | – |
| Q1 2022 | $386,000 | -42.5% | 28,337 | -16.9% | 0.00% | – |
| Q4 2021 | $671,000 | +191.7% | 34,117 | +376.3% | 0.00% | – |
| Q3 2021 | $230,000 | -84.3% | 7,163 | -83.7% | 0.00% | – |
| Q4 2020 | $1,464,000 | +624.8% | 44,078 | +579.0% | 0.00% | – |
| Q4 2019 | $202,000 | – | 6,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |